Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Sep 10, 2015 at 4:18 PM EDT

AbbVie Posts Another Win for Humira

ThinkstockAbbVie Inc. (NYSE: ABBV) has continued to push forward over the past year and shares are actually up 7.3% in…

Chris Lange | Sep 10, 2015 at 2:10 PM EDT

La Jolla Gears Up for Secondary Offering

La Jolla Pharmaceuticals has announced the pricing of an underwritten offering of 2.55 million shares of its common stock.

Jon C. Ogg | Sep 10, 2015 at 10:50 AM EDT

Biogen Follows Gilead With Large Debt Offering

ThinkstockAre biotech companies going to become the next big companies saddled with debt? Most likely not, but two debt offerings…

Chris Lange | Sep 10, 2015 at 7:15 AM EDT

AnaptysBio Gets Ready for IPO

AnaptysBio Inc. has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).

Chris Lange | Sep 9, 2015 at 12:20 PM EDT

Can Akebia Sustain This Move?

Akebia Therapeutics has had a rough time this year, but shares took a sharp left turn in Wednesday's session on…

Chris Lange | Sep 9, 2015 at 11:25 AM EDT

Penumbra Sets Terms for IPO in New Filing

Penumbra Inc. has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).

Jon C. Ogg | Sep 9, 2015 at 11:10 AM EDT

Why Gilead Faces Unenthusiastic Ratings Into Massive Debt Offering

Gilead Sciences is going to raise cash via a huge debt offering. Will this cash be used to fund a…

Chris Lange | Sep 9, 2015 at 10:50 AM EDT

Can Tetraphase Survive This Implosion?

When investors see a drop of almost 80% in a share price, the question of long-term viability is almost impossible…

Jon C. Ogg | Sep 8, 2015 at 11:40 AM EDT

Is the Huge Jump in Nanosphere Sustainable?

24/7 Wall St. wants to see if Tuesday's move in Nanosphere after an FDA OK is sustainable.

Chris Lange | Sep 5, 2015 at 9:15 AM EDT

5 Top Biotech Stocks That Ran This Past Week

Over the past week, a few biotech companies made absolutely massive runs. Here is information about some of them, as…

Chris Lange | Sep 5, 2015 at 9:05 AM EDT

4 New Big FDA Decisions Expected in September

24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of September and…

Chris Lange | Sep 4, 2015 at 11:50 AM EDT

PointClickCare Gears Up for IPO

PointClickCare has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).

Chris Lange | Sep 4, 2015 at 10:35 AM EDT

Is There Another 25% Upside in Medtronic?

On Medtronic, Oppenheimer has an Outperform rating and a $86 price target, implying upside of 25% from current prices.

Chris Lange | Sep 3, 2015 at 2:05 PM EDT

Why Lannett Is Running

Lannett climbed high on Thursday after announcing the signing of a definitive agreement to purchase UCB's generics unit, Kremers Urban,…

Chris Lange | Sep 3, 2015 at 9:50 AM EDT

Q1 Revenue Lifts Medtronic Over Low Earnings Bar

Medtronic reported lower but better-than-expected fiscal first-quarter earnings before the markets opened on Thursday.

1 … 246 247 248 249 250 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

AbbVie Posts Another Win for Humira

La Jolla Gears Up for Secondary Offering

Biogen Follows Gilead With Large Debt Offering

AnaptysBio Gets Ready for IPO

Can Akebia Sustain This Move?

Penumbra Sets Terms for IPO in New Filing

Why Gilead Faces Unenthusiastic Ratings Into Massive Debt Offering

Can Tetraphase Survive This Implosion?

Is the Huge Jump in Nanosphere Sustainable?

5 Top Biotech Stocks That Ran This Past Week

4 New Big FDA Decisions Expected in September

PointClickCare Gears Up for IPO

Is There Another 25% Upside in Medtronic?

Why Lannett Is Running

Q1 Revenue Lifts Medtronic Over Low Earnings Bar

Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Live Nasdaq Composite: Market Rout Deepens as Inflation Hits Three-Year High and Oil Climbs

Are Big Banks Actually Buying XRP Right Now?

Dividend Safety Check: Energy Infrastructure Income ETFs (EMLP, ENFR)

Dividend Safety Check: EWO and Austrian Equity Income

The $30,000 Stock Sale That Subtly Pulled a 68-Year-Old's Social Security Into the Tax Torpedo

Suze Orman Says a $400,000 Rental Gain Can Trigger a $10,600 Medicare Bill and the Closing Date Is the Only Thing You Control

AI Infrastructure Scorecard: Which of These 3 Stocks Is Delivering on Triple-Digit Growth Promises

Are Big Banks Actually Buying XRP Right Now?

Health and Healthcare Articles

All Health and Healthcare Articles

AbbVie Posts Another Win for Humira

La Jolla Gears Up for Secondary Offering

Biogen Follows Gilead With Large Debt Offering

AnaptysBio Gets Ready for IPO

Can Akebia Sustain This Move?

Penumbra Sets Terms for IPO in New Filing

Why Gilead Faces Unenthusiastic Ratings Into Massive Debt Offering

Can Tetraphase Survive This Implosion?

Is the Huge Jump in Nanosphere Sustainable?

5 Top Biotech Stocks That Ran This Past Week

4 New Big FDA Decisions Expected in September

PointClickCare Gears Up for IPO

Is There Another 25% Upside in Medtronic?

Why Lannett Is Running

Q1 Revenue Lifts Medtronic Over Low Earnings Bar

Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Live Nasdaq Composite: Market Rout Deepens as Inflation Hits Three-Year High and Oil Climbs

Are Big Banks Actually Buying XRP Right Now?

Dividend Safety Check: Energy Infrastructure Income ETFs (EMLP, ENFR)

Dividend Safety Check: EWO and Austrian Equity Income

Featured Reads

The $30,000 Stock Sale That Subtly Pulled a 68-Year-Old's Social Security Into the Tax Torpedo

Suze Orman Says a $400,000 Rental Gain Can Trigger a $10,600 Medicare Bill and the Closing Date Is the Only Thing You Control